Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy teenagers
A new study from Professor Malik Peiris investigates potential immune reactions and adverse effects of SARS-CoV-2 vaccines BNT162b2 and CoronaVac among adolescents. Abstract We present an interim analysis of a registered clinical study (NCT04800133) to establish immunobridging with various antibody and cellular immunity markers and to compare the immunogenicity and reactogenicity of 2-dose BNT162b2 and CoronaVac in healthy adolescents as primary objectives. One-dose BNT162b2